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Background:  Left ventricular (LV) structural and functional remodeling, after injury or overload, is said to be related to ventricular arrhythmias. 
However, little is known about LV structural remodeling and arrhythmias. Accordingly, we examined the association between LV structural remodeling 
(hypertrophy, dilatation) and serious ventricular arrhythmias in patients with a depressed ejection fraction (EF) and an implantable cardioverter-
defibrillator (ICD). Thus, we examined the extent of LV hypertrophy (LVH) as well as the patterns of hypertrophic remodeling and their relation to 
ventricular tachycardia (VT) and ventricular fibrillation (VF).
Methods:  Patients who underwent implantation of an ICD between 2006 and 2009 were identified. Patients were included in this study if they 
were followed in our ICD clinic and had echocardiograms demonstrating LV dysfunction. Those with biventricular devices were not included. There 
were 127 patients who met these criteria. Standard echocardiographic methods were used to determine LV mass and chamber size. LVH was 
defined as LV mass > 95 g/m2 in women and > 115 g/m2 in men. Chamber enlargement was used to differentiate eccentric from concentric 
geometry. The diagnoses of VT/VF was made and confirmed by ICD device interrogation and medical record review. Data are mean +/- SD.
Results:  In the 127 patients, VT/VF occurred in 31 (24%). VT/VF was significantly more prevalent in the 57 patients with LVH vs. the 70 patients 
with normal LV mass (33% vs. 17%; p<0.05). Of the 57 patients with LVH, 44 (77%) had eccentric hypertrophy while 13 (23%) had concentric 
hypertrophy. VT/VF was significantly more prevalent in patients with eccentric vs. concentric hypertrophy (41% vs. 8%; p<0.05). EF was not 
significantly different in these two groups (26 +/- 8% vs. 30 +/- 9%; p=ns). Age, indication for ICD, ischemic etiology, and cardiac medications were 
similar between the groups.
Conclusions:  In patients with a low EF, increased LV mass is a significant risk factor for the development of VT/VF. The structural and functional 
remodeling seen in eccentric hypertrophy presents the highest risk of serious ventricular arrhythmia. Such remodeling is an important therapeutic 
target.
